Sort
16,179 grants matching “malaria”
COBRE:Eukaryotic Pathogens Innovation Center (EPIC)
$2,103,380Lesly A Temesvari · Clemson University · P20 · FY2018 · GM
Multiscale Analysis of Immune Responses
$2,101,312Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Southeast Asia Malaria Research Center
$2,100,602Liwang Cui · Pennsylvania State University, The · U19 · FY2011 · AI
Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization
$2,100,000Kenneth D Stuart · Seattle Children'S Hospital · U19 · FY2023 · AI
Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization
$2,100,000Kenneth D Stuart · Seattle Children'S Hospital · U19 · FY2024 · AI
Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization
$2,100,000Kenneth D Stuart · Seattle Children'S Hospital · U19 · FY2025 · AI
Southeast Asia Malaria Research Center
$2,099,401Liwang Cui · Pennsylvania State University, The · U19 · FY2016 · AI
Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site
$2,098,592Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2022 · AI
Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site
$2,095,587Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2021 · AI
Dry Season Ecology of Malaria Vectors
$2,094,113Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Environmental Modifications in sub-Saharan Africa: Changing Epidemiology, Transmission and Pathogenesis of Plasmodium falciparum and P. vivax Malaria
$2,090,612Guiyun Yan · University Of California-Irvine · U19 · FY2020 · AI
PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS: EVALUATION OF MALARIA THERAPEUTICS
$2,088,140Rob Caudle · Duke University · N01 · FY2018 · AI
Malaria Vaccine: Pfs25-rEPA
$2,085,065Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Malaria Vaccines: TBV Antigens as Conjugates with Alternate Carriers
$2,076,094Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Immunoregulation /Immune Recognition In Filarial/Nonfilarial Parasitic Infection
$2,073,222Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization
$2,071,529Kenneth D Stuart · Seattle Children'S Hospital · U19 · FY2022 · AI
Malaria Pathogenesis in young children and vaccine discovery
$2,069,553Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Biodefense/Emerging Infection Vaccine Studies
$2,065,989Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Biodefense/Emerging Infection Vaccine Studies
$2,065,989Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Malaria Operations Research to Improve Malaria Control and Reduce Morbidity and Mortality in Western Kenya
$2,064,000Feiko Olaf Ter Kuile · Tmliverpool School Of Tropical Medicine · U01 · FY2020 · GH
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa
$2,061,446Diane V Havlir · University Of California, San Francisco · P01 · FY2012 · HD
Vanderbilt Vaccine and Treatment Evaluation Unit
$2,059,956Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2022 · AI
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda
$2,058,846Matthew G Dorsey · University Of California, San Francisco · U19 · FY2015 · AI
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda
$2,058,047Matthew G Dorsey · University Of California, San Francisco · U19 · FY2013 · AI
COBRE:Eukaryotic Pathogens Innovation Center (EPIC)
$2,054,534Lesly A Temesvari · Clemson University · P20 · FY2019 · GM